We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

News in brief

Pharmaceutical Law Insight

News in brief

German court invalidates GSK Advair patent


A group of generic drug makers have won a patent challenge in a German court against GlaxoSmithKline’s asthma drug Advair (fluticasone/salmeterol). The German Federal Patents Court ruling followed a hearing in February in which generic firms Mylan, Neolab, Hexal – part of Novartis’ Sandoz unit and Ivax – a unit of Teva Pharmaceuticals challenged the patent on the combination therapy.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click login button.